2024 Expert Speaker Panel

Anthony Loussouarn

Chief Executive Officer

Chelatec

Arthur Braat

Associate Professor

UMC Utrecht

Ashley Mishoe

Vice President - Regulatory Affairs & Quality Assurance

PharmaLogic

Ben Pais

CMO

Nuclidium

Caroline Stokke

Head of Section

Norway

Carsten Nielsen

Co-Founder & Chief executive officer

Minerva Imaging

Christopher Leamon

CSO

Fusion Pharmaceuticals

Daniel Rossetto

Senior Vice President & Head Of Supply Chain & External Manufacturing

ARTBIO

Daniel Steiner

Senior Vice President Research & Technology

Molecular Partners AG

David Bailey

Business Development Manager

SHINE Technologies

Dirk Pleimes

Chief Medical & Scientific Officer

PentixaPharm GmbH

Evrim Gurpinar

Senior Director, Oncology R&D Business Development

AstraZeneca

Eyal Gimshi

Director - Therapeutics

Isotopia Molecular Imaging ltd.

Francesco De Rose

Head of Pharmaceutical Development

Nuclidium

Glenn Flux

Head of Radioisotope Physics

Institute of Cancer Research

Greg Mullen

COO

Ariceum Therapeutics

Gregory Mullen

Chief Executive Officer

Ariceum Therapeutics

Hugo M L Jansen

Chief Executive Officer

RPO Scientific

Isaac Simmonds

AD Radiochemistry

Rayzebio

Jasminka Taleska

Global Director RLT HCS Readiness & RLT Policy Strategy

Novartis AG

Jeevan Virk

RLT Therapeutic Area Strategy Head

Novartis AG

Jenny Karlsson

Senior Director - Targeted Radiopharmaceuticals

Bayer

Jens De Vos

Head of Alliance & Program Management

Precirix

Jeremy Paull

VP Development and Regulatory Affairs

Starpharma Ltd.

Joanna Wiktorowicz

Project Director

PSI CRO

Julie Nonnekens

Associate Professor

Erasmus MC Cancer Institute

Julien Torgue

Chief Scientific Officer

OranoMed

Justine perrin

Post doctoral researcher

Erasmus MC Cancer Institute

Katarina Sjoegreen Gleisner

Professor

Lund University

Laila Quere

Co-Founder & Chief Executive Officer

Aken medical

Laurent Durous

Scientist

Bayer

Leonhard Schaetz

International Head Health System Readiness & Partnership (RLT)

Novartis AG

Luke Brzozowski

Executive Director, Theranostics and Core Facilities

University Health Network

Marc robillard

cso

Tagworks Pharmaceuticals

Marika Nestor

Chief Executive Officer & Co-Founder

Akiram Therapeutics AB

Maritina Rouchota

Partner & Chief Operating Officer

BIOEMTECH Laboratories

Michel Afargan

CTO

Starget Pharma

Ming Xu

Vice President, Product Team Leader (PTL) for RED Oncology

Bayer

Munir Ghesani

Chief of Nuclear Medicine & Associate Professor of Radiology

United Theranostics

Neil Quigley

Team Leader & Senior Global Product Manager

ITM

Neydher Berroteran-Infante

Director - Chemistry, Manufacturing & Controls,Discovery Science

PentixaPharm GmbH

Nina Eissler

Director - Translational Medicine

Affibody AB

Riccardo Canevari

CEO

RadioPharm Theranostics

Sangram Kale

Head of Peptide Discovery

Biosynth

Ulirch Haupts

Chief Scientific Officer & Managing Director

Navigo Proteins GmbH

Vicki Jardine

Vice President - Clinical Development

ARTBIO

Vimal Patel

Vice President - Chemistry Manufacturing & Controls

RadioPharm Theranostics

Vineet Prakash

Consultant in Nuclear Medicine and Radiology

Royal Surrey County Hospital

EVENT GUIDE
REGISTER INTEREST
PARTNER